Synapse - GDMT, Medicine

Results (1898)

Multiple primary cancers in patients undergoing tumor-normal sequencing define novel associations

Journal Article

Liu, Y. L.; Cadoo, K. A.; Mukherjee, S.; Khurram, A.; Tkachuk, K.; Kemel, Y.; Maio, A.; Belhadj, S.; Carlo, M. I.; Latham, A.; more...
Cancer Epidemiology Biomarkers and Prevention (2022)

Fulltext@MSK | Save

Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study

Journal Article

Swisher, E. M.; Aghajanian, C.; O'Malley, D. M.; Fleming, G. F.; Kaufmann, S. H.; Levine, D. A.; Birrer, M. J.; Moore, K. N.; Spirtos, N. M.; Shahin, M. S.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Impact of veliparib, paclitaxel dosing regimen, and germline BRCA status on the primary treatment of serous ovarian cancer – An ancillary data analysis of the VELIA trial

Journal Article

Aghajanian, C.; Swisher, E. M.; Okamoto, A.; Steffensen, K. D.; Bookman, M. A.; Fleming, G. F.; Friedlander, M.; Moore, K. N.; Tewari, K. S.; O'Malley, D. M.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

COVID-19 outcomes of patients with gynecologic cancer in New York City: An updated analysis from the initial surge of the pandemic

Journal Article

Lara, O. D.; Smith, M.; Wang, Y.; O'Cearbhaill, R. E.; Blank, S. V.; Kolev, V.; Carr, C.; Knisely, A.; McEachron, J.; Gabor, L.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Journal Article

Manning-Geist, B. L.; Gordhandas, S. B.; Giri, D. D.; Iasonos, A.; Zhou, Q.; Girshman, J.; O'Cearbhaill, R. E.; Zamarin, D.; Lichtman, S. M.; Sabbatini, P. J.; more...
Gynecologic Oncology (2022)

Fulltext@MSK | Save

Pre-clinical activity of the oral DNA-PK inhibitor, peposertib (M3814), combined with radiation in xenograft models of cervical cancer

Journal Article

Gordhandas, S. B.; Manning-Geist, B.; Henson, C.; Iyer, G.; Gardner, G. J.; Sonoda, Y.; Moore, K. N.; Aghajanian, C.; Chui, M. H.; Grisham, R. N.
Scientific Reports (2022)

Fulltext@MSK | Save

Phase 3, randomized, open-label study of pembrolizumab plus lenvatinib versus chemotherapy for first-line treatment of advanced or recurrent endometrial cancer: ENGOT-en9/LEAP-001

Journal Article

Marth, C.; Tarnawski, R.; Tyulyandina, A.; Pignata, S.; Gilbert, L.; Kaen, D.; Rubio, M. J.; Frentzas, S.; Beiner, M.; Magallanes-Maciel, M.; more...
International Journal of Gynecological Cancer (2022)

Fulltext@MSK | Save

Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: A systematic review of the literature with proposed screening guidelines

Review

Gordhandas, S. B.; Kahn, R.; Sassine, D.; Aviki, E. M.; Baltich Nelson, B.; Catchings, A.; Liu, Y. L.; Lakhman, Y.; Abu-Rustum, N. R.; Park, K. J.; more...
International Journal of Gynecological Cancer (2022)

Fulltext@MSK | Save

Adavosertib with chemotherapy in patients with primary platinum-resistant ovarian, fallopian tube, or peritoneal cancer: An open-label, four-arm, phase II study

Journal Article

Moore, K. N.; Chambers, S. K.; Hamilton, E. P.; Chen, L. M.; Oza, A. M.; Ghamande, S. A.; Konecny, G. E.; Plaxe, S. C.; Spitz, D. L.; Geenen, J. J. J.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition

Journal Article

Chiang, S.; Vasudevaraja, V.; Serrano, J.; Stewart, C. J. R.; Oliva, E.; Momeni-Boroujeni, A.; Jungbluth, A. A.; Da Cruz Paula, A.; da Silva, E. M.; Weigelt, B.; more...
Modern Pathology (2022)

Fulltext@MSK | Save